Comparison of 2-chloroprocaine 1% versus hyperbaric bupivacaine 0.5% for subarachnoid block in pregnant females posted for elective caesarean section

Introduction and Objectives: Caesarean sections generally done under subarachnoid block using 0.5% hyperbaric bupivacaine as the local anaesthetic of choice. As most caesarean sections are of short duration, we decided to study whether 1% 2-chloroprocaine would be suitable alternative to bupivacaine with primary outcome being duration of sensory blockade in elective lower segment caesarean sections. Materials and Methods: In this prospective study, 60 pregnant females belonging to ASA status 1 and 2, posted for elective lower segment caesarean section were equally randomized into two groups. The first group received 1% chloroprocaine 25 mg (2.5 ml, Group CP) and second group received 0.5% hyperbaric bupivacaine 10 mg (2.0 ml, Group B), intrathecally. We measured the level of sensory and motor blockade, duration of sensory blockade and side effects. Results: Mean duration of sensory blockade was 61.83 23.54 minutes for group CP, which is significantly shorter than group B which had 174.67 41.17 minutes (p Value clinically significant incidences of hypotension (53.33% Vs 30%) compared to group CP. Conclusion: Intrathecal low dose 1 % chloroprocaine is a safe and suitable alternative to low dose 0.5% hyperbaric bupivacaine for an uncomplicated elective lower segment caesarean section. Keywords: 1% 2-Chloroprocaine 0.5% Hyperbaric bupivacaine, Subarachnoid block, Lower segment caesarean section.

[1]  J. Poelaert,et al.  Randomised controlled trial of spinal anaesthesia with bupivacaine or 2‐chloroprocaine during caesarean section , 2016, Acta anaesthesiologica Scandinavica.

[2]  D. Ghisi,et al.  Ambulatory surgery with chloroprocaine spinal anesthesia: a review , 2015 .

[3]  J. Förster Short-acting spinal anesthesia in the ambulatory setting , 2014, Current opinion in anaesthesiology.

[4]  Elizabeth A. Alley,et al.  Neuraxial anesthesia for outpatients. , 2014, Anesthesiology clinics.

[5]  M. Vercauteren,et al.  Intrathecal chloroprocaine vs. lidocaine in day‐case surgery: recovery, discharge and effect of pre‐hydration on micturition , 2014, Acta anaesthesiologica Scandinavica.

[6]  J. Sandelin,et al.  Chloroprocaine 40 mg produces shorter spinal block than articaine 40 mg in day‐case knee arthroscopy patients , 2013, Acta anaesthesiologica Scandinavica.

[7]  A. Atchabahian,et al.  The use of 2‐chloroprocaine for spinal anaesthesia , 2013, Acta anaesthesiologica Scandinavica.

[8]  I. Awad,et al.  Neuraxial anesthesia and bladder dysfunction in the perioperative period: a systematic review , 2012, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[9]  G. Neilson,et al.  Selective spinal anesthesia for outpatient transurethral prostatectomy (TURP): randomized controlled comparison of chloroprocaine with lidocaine , 2012, Acta anaesthesiologica Scandinavica.

[10]  F. Vandenbroucke,et al.  Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: a double-blind randomized trial , 2011, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  G. Fanelli,et al.  Intrathecal 2-Chloroprocaine for Lower Limb Outpatient Surgery: A Prospective, Randomized, Double-Blind, Clinical Evaluation , 2006, Anesthesia and analgesia.

[12]  D. Kopacz,et al.  Spinal 2-Chloroprocaine for Surgery: An Initial 10-Month Experience , 2005, Anesthesia and analgesia.

[13]  K. Drasner Chloroprocaine spinal anesthesia: back to the future? , 2005, Anesthesia and analgesia.

[14]  J. E. Pollock Transient Neurologic Symptoms: Etiology, Risk Factors, and Management , 2002, Regional Anesthesia & Pain Medicine.

[15]  K. Drasner,et al.  Transient Neurologic Symptoms after Spinal Anesthesia: An Epidemiologic Study of 1,863 Patients , 1998, Anesthesiology.